首页> 外国专利> Chimeric gene formed by the DNA sequences that encode the antigenic determinants of four proteins of L. infantum and protein encoded by said gene, and pharmaceutical composition useful for preventing and/or treating leishmaniosis in animals or humans

Chimeric gene formed by the DNA sequences that encode the antigenic determinants of four proteins of L. infantum and protein encoded by said gene, and pharmaceutical composition useful for preventing and/or treating leishmaniosis in animals or humans

机译:由DNA序列形成的嵌合基因,所述DNA序列编码婴儿乳杆菌的四种蛋白质的抗原决定簇和由所述基因编码的蛋白质,以及可用于预防和/或治疗动物或人类利什曼病的药物组合物

摘要

Chimeric gene formed by the DNA sequences that encode the antigenic determinants of four proteins of L. infantum, useful for the serological diagnosis of canine Leishmaniosis and protein obtained, that consists of the prior employment of a cloning strategy. A clone is obtained which expresses the protein rLiPO-Ct-Q (pPQI). To this initial vector, by means of the use of suitable restriction targets, DNA fragments are sequentially added that are encoded in other proteins and after each cloning step the correct orientation of each one of the inserts reduces the size of the expression products, the complete nucleotide sequence of the final pPQV clone being determined. A chimeric polypeptide encoded by the chimeric gene is obtained with a molecular mass of 38 kD and with an isoelectric point of 7.37. This chimeric polypeptide is useful for preventing and/or treating leishmaniosis in animals or humans.
机译:由编码 L四种蛋白质的抗原决定簇的DNA序列形成的嵌合基因。婴儿,可用于对犬利什曼病和获得的蛋白质进行血清学诊断,其中包括事先采用克隆策略。获得表达蛋白质rLiPO-Ct-Q(pPQI)的克隆。通过使用合适的限制性靶点,在该初始载体中依次添加其他蛋白质编码的DNA片段,并且在每个克隆步骤之后,每个插入片段的正确方向会减小表达产物的大小,确定最终pPQV克隆的核苷酸序列。得到由嵌合基因编码的嵌合多肽,其分子量为38kD,等电点为7.37。该嵌合多肽可用于预防和/或治疗动物或人类中的利什曼病。

著录项

相似文献

  • 专利
  • 外文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号